The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
DAQO NEW ENERGY CORP SPNSRD ADS NEW 23703Q203   42,156,000 900,000 SH   SOLE   900,000 0 0
JINKOSOLAR HLDG CO LTD SPONSORED ADR 47759T100   40,816,000 800,000 SH   SOLE   800,000 0 0
PDD HOLDINGS INC SPONSORED ADS 722304102   22,770,000 300,000 SH   SOLE   300,000 0 0
TAL EDUCATION GROUP SPONSORED ADS 874080104   46,004,775 7,177,032 SH   SOLE   7,177,032 0 0
VIPSHOP HOLDINGS LIMITED SPONSORED ADS A 92763W103   13,662,000 900,000 SH   SOLE   900,000 0 0
YS BIOPHARMA CO LTD *W EXP 03/15/202 G9845F117   77,800 500,000 SH   SOLE   500,000 0 0
YS BIOPHARMA CO LTD ORDINARY SHARES G9845F109   2,899,107 1,811,942 SH   SOLE   1,811,942 0 0